EUVIMEDEUVIMED entdecken
Open Access

Clinical effect of obinutuzumab in the treatment of idiopathic membranous nephropathy

Shaoxiong Ning, Qian Zhang, Zhixing Shang, Hongting Liu

American Journal of Translational Research · 2026 · 18 (6) · 4777-4790

DOI: 10.62347/hhhf9971 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Translational Research, 2026. Verfasst von Shaoxiong Ning und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Yuncheng Central Hospital Yuncheng 044000, Shanxi, China. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

B-cell depletion therapyObinutuzumabanti-PLA2R antibodyclinical remissionidiopathic membranous nephropathy

Autor:innen und Institutionen

  • Department of Nephrology, Yuncheng Central Hospital Yuncheng 044000, Shanxi, China.
  • Department of Cardiology, Yuncheng Central Hospital Yuncheng 044000, Shanxi, China.

Zitieren

APA

Ning, S., Zhang, Q., Shang, Z., & Liu, H. (2026). Clinical effect of obinutuzumab in the treatment of idiopathic membranous nephropathy. American Journal of Translational Research, 18(6), 4777-4790. https://doi.org/10.62347/hhhf9971

Vancouver

Ning S, Zhang Q, Shang Z, Liu H. Clinical effect of obinutuzumab in the treatment of idiopathic membranous nephropathy. American Journal of Translational Research. 2026;18(6):4777-4790. doi:10.62347/hhhf9971

BibTeX
@article{Ning2026,
  author = {Ning, Shaoxiong and Zhang, Qian and Shang, Zhixing and Liu, Hongting},
  title = {Clinical effect of obinutuzumab in the treatment of idiopathic membranous nephropathy},
  journal = {American Journal of Translational Research},
  year = {2026},
  volume = {18},
  number = {6},
  pages = {4777--4790},
  doi = {10.62347/hhhf9971}
}
Kostenlos starten →